Examination of Setarud (IMOD™) in the management of patients with severe sepsis

BACKGROUND AND THE PURPOSE OF THE STUDY: Analysis of current immunomodulating strategies indicates that monovalent approaches are unlikely to restore immunostasis or achieve complete therapy of sepsis. Setarud (IMOD) as a mixture of urtica, carotenoids, urea, and selenium has been recently patented...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Mahmoodpoor, A., Eslami, K., Mojtahedzadeh, M., Najafi, A., Ahmadi, A., Dehnadi-Moghadam, A., Mohammadirad, A., Baeeri, M., Abdollahi, M.
Format: Artigo
Jezik:Inglês
Izdano: Tehran University of Medical Sciences 2010
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232081/
https://ncbi.nlm.nih.gov/pubmed/22615589
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items